Abstract
Background: The frequency of acute kidney injury (AKI) can be as high as 50% in the intensive care unit (ICU). Despite the publication of national guidelines in France in 2015 for the use of RRT, there are no data describing the implementation of these recommendations in real-life. Methods: We performed a nationwide survey of practices from November 15, 2019, to January 24, 2020, in France. An electronic questionnaire based on the items recommended in the national guidelines was sent using an online survey platform, to the chiefs of all ICUs in France. The questionnaire comprised a section for the Department Chief about local organization and facilities, and a second section destined for individual physicians about their personal practices. Results: We contacted the Department Chief in 356 eligible ICUs, of whom 88 (24.7%) responded regarding their ICU organization. From these 88 ICUs, 232/285 physicians (82%) completed the questionnaire regarding individual practices. The practices reported by respondent physicians were as follows: intermittent RRT was first-line choice in >75% in a patient with single organ (kidney) failure at the acute phase, whereas continuous RRT was predominant (>75%) in patients with septic shock or multi-organ failure. Blood and dialysate flow for intermittent RRT were 200–300 mL/min and 400–600 mL/min, respectively. The dose of dialysis for continuous RRT was 25–35 mL/kg/h (65%). Insertion of the dialysis catheter was mainly performed by the resident under echographic guidance, in the right internal jugular vein. The most commonly used catheter lock was citrate (53%). The most frequently cited criterion for weaning from RRT was diuresis, followed by a drop in urinary markers (urea and creatinine). Conclusion: This study shows a satisfactory level of reported compliance with French guidelines and recent scientific evidence among ICU physicians regarding initiation of RRT for AKI in the ICU.
References
1.
Clec’h
C
, Gonzalez
F
, Lautrette
A
, Nguile-Makao
M
, Garrouste-Orgeas
M
, Jamali
S
, Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis
. Crit Care
. 2011
;15
(3
):R128
. .2.
Poukkanen
M
, Koskenkari
J
, Vaara
ST
, Pettilä
V
, Karlsson
S
, Korhonen
AM
, Variation in the use of renal replacement therapy in patients with septic shock: a substudy of the prospective multicenter observational FINNAKI study
. Crit Care
. 2014 Feb 5
;18
(1
):R26
. .3.
Hoste
EA
, Bagshaw
SM
, Bellomo
R
, Cely
CM
, Colman
R
, Cruz
DN
, Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
. Intensive Care Med
. 2015 Aug
;41
(8
):1411
–23
. .4.
Mehta
RL
, Cerdá
J
, Burdmann
EA
, Tonelli
M
, García-García
G
, Jha
V
, International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology
. Lancet
. 2015 Jun 27
;385
(9987
):2616
–43
. .5.
Ronco
C
, Bellomo
R
, Kellum
JA
. Acute kidney injury
. Lancet
. 2019 Nov 23
;394
(10212
):1949
–64
. .6.
de Mendonca
A
, Vincent
JL
, Suter
PM
, Moreno
R
, Dearden
NM
, Antonelli
M
, Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score
. Intensive Care Med
. 2000 Jul
;26
(7
):915
–21
.7.
Uchino
S
, Kellum
JA
, Bellomo
R
, Doig
GS
, Morimatsu
H
, Morgera
S
, Acute renal failure in critically ill patients: a multinational, multicenter study
. JAMA
. 2005 Aug 17
;294
(7
):813
–8
. .8.
Gomez
H
, Ince
C
, De Backer
D
, Pickkers
P
, Payen
D
, Hotchkiss
J
, A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury
. Shock
. 2014 Jan
;41
(1
):3
–11
. .9.
Mehran
R
, Dangas
GD
, Weisbord
SD
. Contrast-associated acute kidney injury. Reply
. N Engl J Med
. 2019 May 30
;381
(22
):1296
–7
. .10.
Nisula
S
, Kaukonen
KM
, Vaara
ST
, Korhonen
AM
, Poukkanen
M
, Karlsson
S
, Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study
. Intensive Care Med
. 2013 Mar
;39
(3
):420
–8
. .11.
Legrand
M
, Darmon
M
, Joannidis
M
, Payen
D
. Management of renal replacement therapy in ICU patients: an international survey
. Intensive Care Med
. 2013 Jan
;39
(1
):101
–8
. .12.
Jamal
JA
, Mat-Nor
MB
, Mohamad-Nor
FS
, Udy
AA
, Lipman
J
, Roberts
JA
. A national survey of renal replacement therapy prescribing practice for acute kidney injury in Malaysian intensive care units
. Nephrology
. 2014 Aug
;19
(8
):507
–12
. .13.
Fealy
N
, Aitken
L
, Toit
E
, Baldwin
I
. Continuous renal replacement therapy: current practice in Australian and New Zealand intensive care units
. Crit Care Resusc
. 2015 Jun
;17
(2
):83
–91
.14.
Clark
WR
, Ding
X
, Qiu
H
, Ni
Z
, Chang
P
, Fu
P
, Renal replacement therapy practices for patients with acute kidney injury in China
. PLoS One
. 2017
;12
(7
):e0178509
. .15.
Heung
M
, Bagshaw
SM
, House
AA
, Juncos
LA
, Piazza
R
, Goldstein
SL
. CRRTnet: a prospective, multi-national, observational study of continuous renal replacement therapy practices
. BMC Nephrol
. 2017 Jul 6
;18
(1
):222
. .16.
Digvijay
K
, Neri
M
, Fan
W
, Ricci
Z
, Ronco
C
. International survey on the management of acute kidney injury and continuous renal replacement therapies: year 2018
. Blood Purif
. 2019
;47
(1–3
):113
–9
. .17.
Murugan
R
, Ostermann
M
, Peng
Z
, Kitamura
K
, Fujitani
S
, Romagnoli
S
, Net ultrafiltration prescription and practice among critically Ill patients receiving renal replacement therapy: a multinational survey of critical care practitioners
. Crit Care Med
. 2020 Feb
;48
(2
):e87
–97
. .18.
Brochard
L
, Abroug
F
, Brenner
M
, Broccard
AF
, Danner
RL
, Ferrer
M
, An official ATS/ERS/ESICM/SCCM/SRLF statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine
. Am J Respir Crit Care Med
. 2010 May 15
;181
(10
):1128
–55
. .19.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group
. KDIGO clinical practice guideline for acute kidney injury
. Kidney Int
. 2012
;2
(Suppl
):1
–138
.20.
Vinsonneau
C
, Allain-Launay
E
, Blayau
C
, Darmon
M
, Ducheyron
D
, Gaillot
T
, Renal replacement therapy in adult and pediatric intensive care: recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD)
. Ann Intensive Care
. 2015 Dec
;5
(1
):58
. .21.
Ahmed
AR
, Obilana
A
, Lappin
D
. Renal replacement therapy in the critical care setting
. Crit Care Res Pract
. 2019
;2019
:6948710
. .22.
Gaudry
S
, Hajage
D
, Schortgen
F
, Martin-Lefevre
L
, Pons
B
, Boulet
E
, Initiation strategies for renal-replacement therapy in the intensive care unit
. N Engl J Med
. 2016 Jul 14
;375
(2
):122
–33
. .23.
Zarbock
A
, Kellum
JA
, Schmidt
C
, Van Aken
H
, Wempe
C
, Pavenstädt
H
, Effect of early vs delayed initiation of renal replacement therapy on mortality in critically Ill patients with acute kidney injury: the ELAIN randomized clinical trial
. JAMA
. 2016 May 24–31
;315
(20
):2190
–9
. .24.
Barbar
SD
, Clere-Jehl
R
, Bourredjem
A
, Hernu
R
, Montini
F
, Bruyère
R
, Timing of renal-replacement therapy in patients with acute kidney injury and sepsis
. N Engl J Med
. 2018 Oct 11
;379
(15
):1431
–42
. .25.
Gaudry
S
, Hajage
D
, Benichou
N
, Chaïbi
K
, Barbar
S
, Zarbock
A
, Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials
. Lancet
. 2020 May 9
;395
(10235
):1506
–15
. .26.
STARRT-AKI Investigators, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group, United Kingdom Critical Care Research Group, Canadian Nephrology Trials Network, Irish Critical Care Trials Group
; Bagshaw
SM
, Wald
R
, Adhikari
NKJ
, Bellomo
R
, da Costa
BR
, Dreyfuss
D
, Timing of initiation of renal-replacement therapy in acute kidney injury
. N Engl J Med
. 2020 Jul 16
;383
(3
):240
–51
.27.
Thakar
CV
, Rousseau
J
, Leonard
AC
. Timing of dialysis initiation in AKI in ICU: international survey
. Crit Care
. 2012 Dec 19
;16
(6
):R237
. .28.
Seabra
VF
, Balk
EM
, Liangos
O
, Sosa
MA
, Cendoroglo
M
, Jaber
BL
. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis
. Am J Kidney Dis
. 2008 Aug
;52
(2
):272
–84
. .29.
Karvellas
CJ
, Farhat
MR
, Sajjad
I
, Mogensen
SS
, Leung
AA
, Wald
R
, A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis
. Crit Care
. 2011
;15
(1
):R72
. .30.
Wang
X
, Jie Yuan
W
. Timing of initiation of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis
. Ren Fail
. 2012
;34
(3
):396
–402
. .31.
Gaudry
S
, Hajage
D
, Martin-Lefevre
L
, Louis
G
, Moschietto
S
, Titeca-Beauport
D
, The artificial kidney initiation in kidney injury 2 (AKIKI2): study protocol for a randomized controlled trial
. Trials
. 2019 Dec 16
;20
(1
):726
. .32.
Staubach
KH
, Rau
HG
, Kooistra
A
, Schardey
HM
, Hohlbach
G
, Schilberg
FW
. Can hemofiltration increase survival time in acute endotoxemia – a porcine shock model
. Prog Clin Biol Res
. 1989
;308
:821
–6
.33.
Rimmele
T
, Assadi
A
, Cattenoz
M
, Desebbe
O
, Lambert
C
, Boselli
E
, High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs
. Nephrol Dial Transplant
. 2009 Feb
;24
(2
):421
–7
.34.
Payen
D
, Mateo
J
, Cavaillon
JM
, Fraisse
F
, Floriot
C
, Vicaut
E
, Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial
. Crit Care Med
. 2009 Mar
;37
(3
):803
–10
. .35.
Joannes-Boyau
O
, Honoré
PM
, Perez
P
, Bagshaw
SM
, Grand
H
, Canivet
JL
, High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial
. Intensive Care Med
. 2013 Sep
;39
(9
):1535
–46
. .36.
Quenot
JP
, Binquet
C
, Vinsonneau
C
, Barbar
SD
, Vinault
S
, Deckert
V
, Very high volume hemofiltration with the Cascade system in septic shock patients
. Intensive Care Med
. 2015 Dec
;41
(12
):2111
–20
. .37.
Vinsonneau
C
, Camus
C
, Combes
A
, Costa de Beauregard
MA
, Klouche
K
, Boulain
T
, Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial
. Lancet
. 2006 Jul 29
;368
(9533
):379
–85
. .38.
Rabindranath
K
, Adams
J
, Macleod
AM
, Muirhead
N
. Intermittent versus continuous renal replacement therapy for acute renal failure in adults
. Cochrane Database Syst Rev
. 2007 Jul 18
;(3
):CD003773
. .39.
Bagshaw
SM
, Berthiaume
LR
, Delaney
A
, Bellomo
R
. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis
. Crit Care Med
. 2008 Feb
;36
(2
):610
–7
. .40.
Bell
M
, Swing
, Granath
F
, Schön
S
, Ekbom
A
, Martling
CR
. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure
. Intensive Care Med
. 2007 May
;33
(5
):773
–80
. .41.
Schneider
AG
, Bellomo
R
, Bagshaw
SM
, Glassford
NJ
, Lo
S
, Jun
M
, Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis
. Intensive Care Med
. 2013 Jun
;39
(6
):987
–97
. .42.
Schiffl
H
, Lang
SM
, Fischer
R
. Daily hemodialysis and the outcome of acute renal failure
. N Engl J Med
. 2002 Jan 31
;346
(5
):305
–10
. .43.
VA/NIH Acute Renal Failure Trial Network
; Palevsky
PM
, Palevsky
PM
, Zhang
JH
, O'Connor
TZ
, Chertow
GM
, Crowley
ST
, Intensity of renal support in critically ill patients with acute kidney injury
. N Engl J Med
. 2008 Jul 3
;359
(1
):7
–20
. .44.
Faulhaber-Walter
R
, Hafer
C
, Jahr
N
, Vahlbruch
J
, Hoy
L
, Haller
H
, The Hannover dialysis outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit
. Nephrol Dial Transplant
. 2009 Jul
;24
(7
):2179
–86
. .45.
Investigators
RRTS
, Bellomo
R
, Cass
A
, Cole
L
, Finfer
S
, Gallagher
M
, Intensity of continuous renal-replacement therapy in critically ill patients
. N Engl J Med
. 2009 Oct 22
;361
(17
):1627
–38
. .46.
Parienti
JJ
, Thirion
M
, Mégarbane
B
, Souweine
B
, Ouchikhe
A
, Polito
A
, Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial
. JAMA
. 2008 May 28
;299
(20
):2413
–22
. .47.
Hermite
L
, Quenot
JP
, Nadji
A
, Barbar
SD
, Charles
PE
, Hamet
M
, Sodium citrate versus saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adults: a randomized controlled trial
. Intensive Care Med
. 2012 Feb
;38
(2
):279
–85
. .48.
Parienti
JJ
, Deryckère
S
, Mégarbane
B
, Valette
X
, Seguin
A
, Sauneuf
B
, Quasi-experimental study of sodium citrate locks and the risk of acute hemodialysis catheter infection among critically ill patients
. Antimicrob Agents Chemother
. 2014 Oct
;58
(10
):5666
–72
. .49.
Quenot
JP
, Helms
J
, Bourredjem
A
, Dargent
A
, Meziani
F
, Badie
J
, Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial
. Ann Intensive Care
. 2019 Jul 1
;9
(1
):75
. .50.
Bovet
J
, Soudry-Faure
A
, Merdji
H
, Ksiazek
E
, Quenot
JP
, Meziani
F
, Evaluation of anti-Xa activity after injection of a heparin lock for dialysis catheters in intensive care: a prospective observational study
. Thromb Res
. 2020 Apr
;188
:82
–4
. .51.
Hetzel
GR
, Schmitz
M
, Wissing
H
, Ries
W
, Schott
G
, Heering
PJ
, Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial
. Nephrol Dial Transplant
. 2011 Jan
;26
(1
):232
–9
. .52.
Wu
MY
, Hsu
YH
, Bai
CH
, Lin
YF
, Wu
CH
, Tam
KW
. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials
. Am J Kidney Dis
. 2012 Jun
;59
(6
):810
–8
. .53.
Zhang
Z
, Hongying
N
. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy
. Intensive Care Med
. 2012 Jan
;38
(1
):20
–8
. .54.
Schortgen
F
, Soubrier
N
, Delclaux
C
, Thuong
M
, Girou
E
, Brun-Buisson
C
, Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines
. Am J Respir Crit Care Med
. 2000 Jul
;162
(1
):197
–202
. .55.
Graham
P
, Lischer
E
. Nursing issues in renal replacement therapy: organization, manpower assessment, competency evaluation and quality improvement processes
. Semin Dial
. 2011 Mar–Apr
;24
(2
):183
–7
. .56.
Beloucif
S
, Payen
D
. A European survey of the use of inhaled nitric oxide in the ICU. Working Group on Inhaled NO in the ICU of the European Society of Intensive Care Medicine
. Intensive Care Med
. 1998 Aug
;24
(8
):864
–77
. .57.
Cannesson
M
, Pestel
G
, Ricks
C
, Hoeft
A
, Perel
A
. Hemodynamic monitoring and management in patients undergoing high risk surgery: a survey among North American and European anesthesiologists
. Crit Care
. 2011 Aug 15
;15
(4
):R197
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
